Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Sanofi
02 1Biophore India Pharmaceuticals Pvt Ltd
03 2Dr. Reddy's Laboratories
04 1NanoAlvand
05 1Supriya Lifescience
06 4Accord healthcare
07 1Amneal Pharmaceuticals
08 2Arrotex Pharmaceuticals
09 1Aurobindo Pharma Limited
10 1Auxilia Pharma Oü
11 4Eugia Pharma
12 1GLAND PHARMA LIMITED
13 1Glenmark Pharmaceuticals
14 2Hetero Drugs
15 1JAMP PHARMA
16 1MSN Laboratories
17 1Meitheal Pharmaceuticals
18 1Naprod Life Sciences
19 1ORIFARM GROUP AS
20 4SEACROSS PHARMACEUTICALS
21 1STADA Arzneimittel
22 1Tarbis Farma Sl
23 4Teva Pharmaceutical Industries
24 1Tillomed Laboratories Ltd
25 2Viatris
26 2Vivanta Generics Sro
27 1Vivanta Generics sro
28 1Zydus Pharmaceuticals
01 2INJ
02 1Injectable
03 15Injectable Solution
04 2Injection
05 6Injection Solution
06 1Liquid Injection
07 1Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
08 2SOLUTION
09 10SOLUTION;SUBCUTANEOUS
10 6Solution For Injection
11 1Vial
12 4Blank
01 1Allowed
02 6Approved
03 8Authorized
04 1DISCN
05 1Generic
06 3Marketed
07 1Not Marketed
08 1Originator
09 10Prescription
10 9RX
11 10Blank
01 1Heterix 24
02 1MOZOBIL
03 7Mozobil
04 1Neofor
05 9PLERIXAFOR
06 2PLERIXAFOR EUGIA
07 2PLERIXAFOR INJECTION
08 1Plerazafor Accord
09 1Plerixafor
10 2Plerixafor ARX
11 3Plerixafor Accord
12 1Plerixafor Auxilia
13 1Plerixafor Eugia
14 1Plerixafor Glenmark
15 3Plerixafor Seacross
16 1Plerixafor Stada
17 1Plerixafor Tarbis
18 2Plerixafor Teva
19 1Plerixafor Tillomed
20 1Plerixafor Viatris
21 2Plerixafor Vivanta
22 1Plerixafor "Seacross"
23 1Plerixafor "Teva"
24 1Plerixafor "Viatris"
25 1Plerixafor "Vivanta"
26 3Blank
01 4Australia
02 2Canada
03 6Denmark
04 2Estonia
05 4India
06 1Iran
07 1Italy
08 4Norway
09 2South Africa
10 8Spain
11 6Sweden
12 1Switzerland
13 10USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : RX
Registration Country : USA
Brand Name : MOZOBIL
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2008-12-15
Application Number : 22311
Regulatory Info : RX
Registration Country : USA
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 205182
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Neofor
Dosage Form : Vial
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 24MG/1.2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Mozobil
Dosage Form : Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
Dosage Strength : 1 bottle SC 24 mg 20 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 15/08/2014
Application Number : 63139
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 31/07/2009
Application Number : 20080608000019
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20MG
Packaging :
Approval Date : 12-11-2009
Application Number : 9537001
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Mozobil
Dosage Form : INJ
Dosage Strength : 20mg/ml
Packaging : 1.2X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Mozobil
Dosage Form : Injection Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 31-07-2009
Application Number : 28104372608
Regulatory Info : Prescription
Registration Country : Denmark
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Plerixafor
Dosage Form : Injectable
Dosage Strength : 20 mg/ml (1.2 ml)
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 215334
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 213672
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2024-05-03
Application Number : 206644
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2025-06-16
Application Number : 217560
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 215698
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 211901
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-24
Application Number : 205197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PLERIXAFOR
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 24MG/1.2ML (20MG/ML)
Packaging :
Approval Date : 2023-07-26
Application Number : 208980
Regulatory Info : DISCN
Registration Country : USA
